The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BBI608-503-103HCC: A phase Ib/II clinical study of napabucasin (BBI608) in combination with sorafenib or amcasertib (BBI503) in combination with sorafenib (Sor) in adult patients with hepatocellular carcinoma (HCC).
 
Bassel F. El-Rayes
Consulting or Advisory Role - BTG; Genentech/Roche; Merrimack; Merrimack
Research Funding - AVEO (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); Novartis (Inst); Pfizer (Inst); PPD (Inst); Taiho Pharmaceutical (Inst)
 
Donald A. Richards
Consulting or Advisory Role - Boehringer Ingelheim; Insys Therapeutics; IntegraGen; Lilly; Merrimack; Pharmacyclics
Speakers' Bureau - Celgene
 
Allen Lee Cohn
Honoraria - Bristol-Myers Squibb; Merrimack; Roche/Genentech
Speakers' Bureau - Merrimack
 
Stephen Lane Richey
Employment - Texas Oncology
Consulting or Advisory Role - Exelixis; Prometheus; Sanofi
Research Funding - Abbvie; Acerta Pharma; Aptiv Solutions; Bayer Schering Pharma; Biothera; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Celgene; Cerulean Pharma; Daiichi Sankyo; Dendreon; Eisai; Genentech/Roche; Gilead Sciences; GlaxoSmithKline/Novartis; HUYA Bioscience International; ImClone Systems; Immunomedics; Janssen Oncology; Lilly; MedImmune; Merck; Merck; Merrimack; Nektar; Novartis; Oncolytics; Oncothyreon; Pharm-Olam; RTOG; Seagen; US Oncology
 
Trevor Feinstein
No Relationships to Disclose
 
Madappa N. Kundranda
Honoraria - Amgen; Bayer; Celgene
Consulting or Advisory Role - Amgen; Bayer; Celgene
Speakers' Bureau - Amgen; Bayer; Celgene
 
Anthony B. El-Khoueiry
Honoraria - Bayer; Bristol-Myers Squibb; Merrimack; Novartis
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; CytomX Therapeutics
Speakers' Bureau - Merrimack
 
Jason M. Melear
No Relationships to Disclose
 
Fadi S. Braiteh
Stock and Other Ownership Interests - Agios; Bristol-Myers Squibb; Clovis Oncology; Insys Therapeutics; Tesaro
Honoraria - Abbott Nutrition; Amgen; ARIAD; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; HERON; Incyte; Insys Therapeutics; Insys Therapeutics; Ipsen; Lexicon; Lilly; Taiho Pharmaceutical
Consulting or Advisory Role - Ambry Genetics; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Ipsen; Lexicon; Lilly; Merck; Merrimack; Pfizer; Regeneron; Sanofi
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Lilly; Merck; Merck; Merrimack; Pfizer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Bayer; Bayer/Onyx; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Exelixis; HERON; Incyte; Insys Therapeutics; Ipsen; Lexicon; Merrimack; Novartis; Pfizer; Regeneron; Roche/Genentech; Sanofi; Taiho Pharmaceutical; Tesaro
 
Matthew Hitron
Employment - Boston Biomedical
 
Waldo Feliu Ortuzar
Employment - Boston Biomedical
 
Waheed Khan
Employment - Boston Biomedical
 
Bo Xu
Employment - Boston Biomedical
Stock and Other Ownership Interests - Boston Biomedical
 
Wei Li
Employment - Boston Biomedical
Stock and Other Ownership Interests - Boston Biomedical
 
Youzhi Li
Employment - Boston Biomedical
Stock and Other Ownership Interests - Boston Biomedical
 
C J Li
Employment - Boston Biomedical
Stock and Other Ownership Interests - Boston Biomedical